// App-Quantinova.ai

S111 : REPEATED INFUSIONS OF ESCALATING DOSES OF EXPANDED AND ACTIVATED AUTOLOGOUS NATURAL KILLER CELLS IN MINIMAL RESIDUAL DISEASE-POSITIVE PH+ ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS. A GIMEMA PHASE 1 TRIAL

Researchers

Presenter

  • Giovanni Fernando Torelli

Principal Investigators

  • Sabina Chiaretti

  • Nadia Peragine

  • Walter Barberi

  • Laura Santodonato

  • Giuseppina D'Agostino

  • Elisabetta Abruzzese

  • Maria Ilaria Del Principe

  • Alessandra Mancino

  • Mabel Matarazzo

  • Marco Mancini

  • Monica Messina

  • Luciano Castiello

  • Anna Guarini

  • Robin Fo

Medical Centers

  • Hematology Department,

  • Hematology, Department of Translational and Precision Medicine,Sapienza University,Rome,Italien

  • Hematology, Department of Translational and Precision Medicine,Sapienza University,Rome,Italien

  • Hematology,Sant'Eugenio Hospital, ASL Roma2, Tor Vergata University,Rome,Italia

  • Hematology, Department of Translational and Precision Medicine,Sapienza University,Rome,Italien

  • FaBioCell, Core Facilities, Istituto Superiore di Sanità, Rome, Italy

  • Hematology, Department of Translational and Precision Medicine,Sapienza University,Rome,Italien

  • Hematology Depa

  • Hematology,Sant'Eugenio Hospital, ASL Roma2, Tor Vergata University,Rome,Italia

  • FaBioCell Cell Factory,Istituto Superiore di Sanità,Rome,Italien

  • FaBioCell Cell Factory,Istituto Superiore di Sanità,Rome,Italien

  • Fondazione GIMEMA Onlus,Rome,Italia

  • Hematology, Department of Translational and Precision Medicine,Sapienza University,Rome,Italien

  • FaBioCell Cell Factory,Istituto Superiore di Sanità,Rome,Italien

  • Hematology, Department of Translational and Precision Medicine,Sapienza University,Rome,Italien

  • Fondazione GIMEMA Onlus,Rome,Italia

  • Hematology Dpt of Biomedicine and Prevention, Tor Vergata Unversity, Rome, Italy

  • Hematology, Department of Translational and Precision Medicine,Sapienza University,Rome,Italien

  • Hematology, Department of Biomedicine and Preven

  • Fondazione GIMEMA Onlus,Rome,Italia

  • Hematology,Sant'Eugenio Hospital, ASL Roma2, Tor Vergata University,Rome,Italia

  • FaBioCell Cell Factory,Istituto Superiore di Sanità,Rome,Italien

  • Fondazione GIMEMA, Rome, Italy

  • Fondazione GIMEMA Onlus,Rome,Italia

  • Fondazione GIMEMA Onlus,Rome,Italia

  • Hematology Dpt of Biomedicine and Prevention, Tor Vergata Unversity, Rome, Italy

  • Hematology Dpt of Biomedicine and Prevention, Tor Vergata Unversity, Rome, Italy

  • FaBioCell Cell F

  • Hematology,Sant'Eugenio Hospital, ASL Roma2, Tor Vergata University,Rome,Italia

  • Fondazione GIMEMA Onlus,Rome,Италия

  • Hematology Dpt of Biomedicine and Prevention, Tor Vergata Unversity, Rome, Italy

  • Hematology, Department of Translational and Precision Medicine,Sapienza University,Rome,Italien

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Natural Killer cells

  • Peripheral blood mononuclear cell

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved